Product Information
ROPINIROLE HCL 4 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.0818 per EA under NDC 69452036120. Its NADAC has been published 172 times since May 10, 2023.
FDA first approved this application on Nov 28, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Bionpharma Inc.NDC
69452036120
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079229FDA Approved
11/28/2012
TE Code
AB
On Market Since
9/15/2022
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 4 MG TABLET has been published 172 times since May 10, 2023, and over the history we have for it it has declined 4.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0818 per EA |
|---|---|
| All-time high | $0.0962 (Jan 10, 2024) |
| All-time low | $0.0681 (Nov 20, 2024) |
| 52-week high | $0.0852 |
| 52-week low | $0.0771 |
| Median price | $0.0816 |
| Average price | $0.0811 |
| Largest weekly change | -23.6% (Apr 17, 2024) |
| Weeks tracked | 172 |
| Tracking since | May 10, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 4 MG TABLET, manufactured by Bionpharma Inc., is $0.0818 per EA (NDC 69452036120), effective Aug 19, 2026.
How has the price of ROPINIROLE HCL 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 4 MG TABLET has declined 4.9%. It has been tracked across 172 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 4 MG TABLET?
Since May 10, 2023, the NADAC for ROPINIROLE HCL 4 MG TABLET has ranged from a low of $0.0681 (Nov 20, 2024) to a high of $0.0962 (Jan 10, 2024), with a median of $0.0816 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 4 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ROPINIROLE HCL 4 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ROPINIROLE HCL 4 MG TABLET?
ROPINIROLE HCL 4 MG TABLET (NDC 69452036120) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.